$INSP
Inspire Medical Systems, Inc.

2018 Q4 Form 10-Q Financial Statement

#000160955018000012 Filed on November 06, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $16.56M $13.05M $7.271M
YoY Change 66.31% 79.54%
Cost Of Revenue $3.190M $2.467M $1.565M
YoY Change 69.68% 57.64%
Gross Profit $13.37M $10.59M $5.706M
YoY Change 65.5% 85.54%
Gross Profit Margin 80.72% 81.1% 78.48%
Selling, General & Admin $16.11M $24.78M $8.179M
YoY Change 57.32% 202.93%
% of Gross Profit 120.53% 234.03% 143.34%
Research & Development $2.150M $1.771M $1.176M
YoY Change 27.98% 50.6%
% of Gross Profit 16.09% 16.73% 20.61%
Depreciation & Amortization $100.0K $100.0K $70.00K
YoY Change -16.67% 42.86%
% of Gross Profit 0.75% 0.94% 1.23%
Operating Expenses $18.27M $15.24M $9.355M
YoY Change 53.27% 62.86%
Operating Profit -$4.904M -$4.649M -$3.649M
YoY Change 27.58% 27.4%
Interest Expense $130.0K $680.0K $428.0K
YoY Change -128.89% 58.88%
% of Operating Profit
Other Income/Expense, Net -$10.00K -$44.00K -$374.0K
YoY Change -125.0% -88.24%
Pretax Income -$4.780M -$4.693M -$4.023M
YoY Change 12.47% 16.65%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.778M -$4.693M -$4.022M
YoY Change 12.37% 16.68%
Net Earnings / Revenue -28.85% -35.95% -55.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$162.4K -$219.6K -$198.6K
COMMON SHARES
Basic Shares Outstanding 21.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $188.2M $120.4M
YoY Change
Cash & Equivalents $97.29M $26.31M $14.54M
Short-Term Investments $90.90M $94.10M
Other Short-Term Assets $1.700M $1.000M
YoY Change
Inventory $2.667M $3.075M
Prepaid Expenses $1.734M $1.044M
Receivables $6.667M $5.410M
Other Receivables $0.00 $0.00
Total Short-Term Assets $199.3M $130.0M
YoY Change 726.98%
LONG-TERM ASSETS
Property, Plant & Equipment $802.0K $765.0K
YoY Change -19.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $802.0K $765.0K
YoY Change -19.32%
TOTAL ASSETS
Total Short-Term Assets $199.3M $130.0M
Total Long-Term Assets $802.0K $765.0K
Total Assets $200.1M $130.7M
YoY Change 697.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.400M $2.400M
YoY Change
Accrued Expenses $7.726M $4.962M
YoY Change 86.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.16M $7.595M
YoY Change 56.08%
LONG-TERM LIABILITIES
Long-Term Debt $24.90M $24.80M
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $24.93M $24.81M
YoY Change 50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.16M $7.595M
Total Long-Term Liabilities $24.93M $24.81M
Total Liabilities $36.08M $32.41M
YoY Change 51.83%
SHAREHOLDERS EQUITY
Retained Earnings -$146.9M -$142.1M
YoY Change 17.45%
Common Stock $23.00K $21.00K
YoY Change 2200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $164.0M $98.31M
YoY Change
Total Liabilities & Shareholders Equity $200.1M $130.7M
YoY Change 697.42%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$4.778M -$4.693M -$4.022M
YoY Change 12.37% 16.68%
Depreciation, Depletion And Amortization $100.0K $100.0K $70.00K
YoY Change -16.67% 42.86%
Cash From Operating Activities -$2.580M -$3.560M -$3.120M
YoY Change -21.34% 14.1%
INVESTING ACTIVITIES
Capital Expenditures -$190.0K $0.00 -$120.0K
YoY Change 216.67% -100.0%
Acquisitions
YoY Change
Other Investing Activities $3.810M -$92.03M -$4.800M
YoY Change -259.41% 1817.29%
Cash From Investing Activities $3.620M -$92.03M -$4.920M
YoY Change -247.76% 1770.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 69.91M 40.00K 80.00K
YoY Change 49835.71% -50.0%
NET CHANGE
Cash From Operating Activities -2.580M -3.560M -3.120M
Cash From Investing Activities 3.620M -92.03M -4.920M
Cash From Financing Activities 69.91M 40.00K 80.00K
Net Change In Cash 70.95M -95.55M -7.960M
YoY Change -1369.23% 1100.38%
FREE CASH FLOW
Cash From Operating Activities -$2.580M -$3.560M -$3.120M
Capital Expenditures -$190.0K $0.00 -$120.0K
Free Cash Flow -$2.390M -$3.560M -$3.000M
YoY Change -25.78% 18.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4032000 USD
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4962000 USD
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2871000 USD
us-gaap Cost Of Revenue
CostOfRevenue
4137000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7595000 USD
CY2017Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
16617000 USD
CY2018Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3619000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 USD
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21391590 shares
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
21000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-11.45
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12514000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001609550
insp Sharebased Compensation Noncash Services
SharebasedCompensationNoncashServices
37000 USD
CY2017Q4 insp Total Authorized Shares
TotalAuthorizedShares
186894620 shares
CY2018Q3 insp Total Authorized Shares
TotalAuthorizedShares
210000000 shares
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21400367 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Inspire Medical Systems, Inc.
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q2 insp Reclassification Of Warrant Liability To Additional Paid In Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital
855000 USD
CY2018Q2 insp Reclassification Of Warrant Liability To Additional Paid In Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital
855000 USD
CY2018Q2 insp Reverse Stock Split Conversion Ratio
ReverseStockSplitConversionRatio
0.150
insp Sharebased Compensation Noncash Services
SharebasedCompensationNoncashServices
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.40
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16105000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-4023000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13260000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-4693000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17050000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-374000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1103000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1569000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
723000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
9355000 USD
us-gaap Operating Expenses
OperatingExpenses
26630000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
15236000 USD
CY2018Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
946000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
810000 USD
CY2017Q3 us-gaap Advertising Expense
AdvertisingExpense
1400000 USD
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
788000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
231000 USD
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7305000 USD
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
240451000 USD
us-gaap Advertising Expense
AdvertisingExpense
3700000 USD
CY2018Q3 us-gaap Advertising Expense
AdvertisingExpense
2000000 USD
us-gaap Operating Expenses
OperatingExpenses
42652000 USD
us-gaap Advertising Expense
AdvertisingExpense
5800000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
189000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
372000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
696000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000 USD
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
456000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14252134 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2279014 shares
CY2017Q4 us-gaap Assets
Assets
25091000 USD
CY2018Q3 us-gaap Assets
Assets
130720000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
24097000 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
129955000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
26000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
7188000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4000 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94140000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
7188000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94114000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
400000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6685000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14540000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8955000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26312000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7855000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
17357000 USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3649000 USD
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1272360 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21391590 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1272360 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4023000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13260000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12157000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4649000 USD
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
2467000 USD
us-gaap Cost Of Revenue
CostOfRevenue
6863000 USD
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
174000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
288000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
288000 USD
CY2017Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
157000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
385056 shares
CY2018Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
0 USD
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.42
us-gaap Operating Income Loss
OperatingIncomeLoss
-15481000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2043000 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M12D
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2400000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
952000 USD
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2018Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2018Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1043000 USD
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2018Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-595000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
48000 USD
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
864000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2552000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2153000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
12250000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10208000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5503000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
5706000 USD
us-gaap Gross Profit
GrossProfit
14473000 USD
CY2018Q3 us-gaap Gross Profit
GrossProfit
10587000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
us-gaap Gross Profit
GrossProfit
27171000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4023000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
16460000 USD
CY2018Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
24814000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13260000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25521000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120473000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
445000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-549000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
593000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
997000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-312000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-595000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
93000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
618000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1105000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1552000 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
428000 USD
us-gaap Interest Expense
InterestExpense
1224000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
680000 USD
us-gaap Interest Expense
InterestExpense
2615000 USD
us-gaap Interest Paid Net
InterestPaidNet
984000 USD
us-gaap Interest Paid Net
InterestPaidNet
1453000 USD
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
117000 USD
CY2018Q3 us-gaap Interest Payable Current
InterestPayableCurrent
184000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2347000 USD
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2021000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
3670000 USD
CY2018Q3 us-gaap Inventory Net
InventoryNet
3075000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1323000 USD
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1054000 USD
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
518000 USD
CY2018Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
813000 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
55000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
119000 USD
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
641000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1049000 USD
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2998000 USD
CY2018Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2449000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3858000 USD
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5410000 USD
CY2018Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
24814000 USD
CY2017Q1 us-gaap Line Of Credit
LineOfCredit
16500000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2071616 shares
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4719000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17076000 USD
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
1565000 USD
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2198130 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.47
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.90
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.04
CY2018Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4693000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17050000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
2.80
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
54.99
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
103000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25091000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130720000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5152000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87011000 USD
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
84136000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
52975000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M22D
CY2018Q3 us-gaap Long Term Debt
LongTermDebt
24500000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2042000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7147000 USD
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
438000 USD
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
397000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 USD
CY2015Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
72000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4802000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
98936000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
11984000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95000 USD
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11312000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31913000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
431000 USD
us-gaap Profit Loss
ProfitLoss
-13260000 USD
us-gaap Profit Loss
ProfitLoss
-17050000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1804000 USD
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1553000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
189000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
696000 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
7188000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
994000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1307821 shares
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
76235050 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
31428 shares
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
458000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8000000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125085000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142135000 USD
CY2017Q3 us-gaap Revenues
Revenues
7271000 USD
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
76894620 shares
us-gaap Revenues
Revenues
18610000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
350000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59000 USD
CY2017 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
76235050 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
119106000 USD
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
426000 USD
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1044000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112042000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
24968000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
765000 USD
CY2017Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
9000000 USD
CY2018Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
16200000 USD
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
829000 USD
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
305000 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1176000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4512000 USD
CY2018Q3 us-gaap Revenues
Revenues
13054000 USD
us-gaap Revenues
Revenues
34034000 USD
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7315000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19566000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1771000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5236000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2018Q3 us-gaap Short Term Investments
ShortTermInvestments
94114000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
227114 shares
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1327000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
98311000 USD
CY2017Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2018Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-26000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-26000 USD
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1176679 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1158548 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21361739 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12137512 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash equivalents and accounts receivable. We believe that the credit risk in our accounts receivable is mitigated by our credit evaluation process, relatively short collection terms, and dispersion of our customer base. We generally do not require collateral, and losses on accounts receivable have historically been within management's expectations.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our investment policy limits investments to certain types of debt securities issued by the U.S. government and its agencies, corporations with investment-grade credit ratings, or commercial paper and money market funds issued by the highest quality financial and non-financial companies. We place restrictions on maturities and concentration by type and issuer. We are exposed to credit risk in the event of a default by the issuers of these securities to the extent recorded on the balance sheets. However, as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we limited our credit risk associated with cash equivalents by placing investments with banks we believe are highly creditworthy.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements. We use significant judgment when making estimates related to the allowance for doubtful accounts, inventory reserves and the valuations of our common stock, share-based awards, and certain of our previously outstanding preferred stock warrants. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001609550-18-000012-index-headers.html Edgar Link pending
0001609550-18-000012-index.html Edgar Link pending
0001609550-18-000012.txt Edgar Link pending
0001609550-18-000012-xbrl.zip Edgar Link pending
a2018-q310q.htm Edgar Link pending
a2018-q3ex31x1.htm Edgar Link pending
a2018-q3ex31x2.htm Edgar Link pending
a2018-q3ex32x1.htm Edgar Link pending
a2018-q3ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
insp-20180930.xml Edgar Link completed
insp-20180930.xsd Edgar Link pending
insp-20180930_cal.xml Edgar Link unprocessable
insp-20180930_def.xml Edgar Link unprocessable
insp-20180930_lab.xml Edgar Link unprocessable
insp-20180930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending